SARTORIUS AG-VORZUG (SRT3.DE) Stock Overview
Europe - FRA:SRT3 - DE0007165631
SRT3.DE Key Statistics, Chart & Performance
The current stock price of SRT3.DE is 236.3 EUR. In the past month the price increased by 6.83%. In the past year, price decreased by -2.96%.
SRT3.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TN8.DE | THERMO FISHER SCIENTIFIC INC | 25.38 | 184.48B | ||
| DAP.DE | DANAHER CORP | 28.2 | 133.89B | ||
| LO3.DE | LONZA GROUP AG-REG | 36.46 | 42.78B | ||
| QTS.DE | IQVIA HOLDINGS INC | 19.24 | 32.26B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 59.1 | 20.13B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 59.69 | 20.33B | ||
| SRT.DE | SARTORIUS AG | 41.45 | 14.15B | ||
| ILU.DE | ILLUMINA INC | 23.63 | 13.00B | ||
| ESF0.DE | EUROFINS SCIENTIFIC | 17.53 | 11.49B | ||
| ERF.PA | EUROFINS SCIENTIFIC | 16.84 | 11.04B | ||
| QIA.DE | QIAGEN N.V. | 20 | 8.76B | ||
| 1BRKR.MI | BRUKER CORP | 16.34 | 5.00B |
Related stock screener links
About SRT3.DE
Company Profile
Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,878 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Company Info
SARTORIUS AG-VORZUG
Otto-Brenner-Str. 20
Goettingen NIEDERSACHSEN DE
Employees: 13878
Phone: 495513080
SARTORIUS AG-VORZUG / SRT3.DE FAQ
What does SARTORIUS AG-VORZUG do?
Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,878 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
What is the current price of SRT3 stock?
The current stock price of SRT3.DE is 236.3 EUR. The price decreased by -0.8% in the last trading session.
What is the dividend status of SARTORIUS AG-VORZUG?
SARTORIUS AG-VORZUG (SRT3.DE) has a dividend yield of 0.38%. The yearly dividend amount is currently 0.74.
What is the ChartMill rating of SARTORIUS AG-VORZUG stock?
SRT3.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is SRT3.DE stock listed?
SRT3.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the analyst forecast for SRT3.DE stock?
8 analysts have analysed SRT3.DE and the average price target is 314.94 EUR. This implies a price increase of 33.28% is expected in the next year compared to the current price of 236.3.
SRT3.DE Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to SRT3.DE. When comparing the yearly performance of all stocks, SRT3.DE turns out to be only a medium performer in the overall market: it outperformed 68.34% of all stocks.
SRT3.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE. SRT3.DE may be in some trouble as it scores bad on both profitability and health.
SRT3.DE Financial Highlights
Over the last trailing twelve months SRT3.DE reported a non-GAAP Earnings per Share(EPS) of 4.56. The EPS increased by 59.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.8% | ||
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| Debt/Equity | 1.28 |
SRT3.DE Forecast & Estimates
8 analysts have analysed SRT3.DE and the average price target is 314.94 EUR. This implies a price increase of 33.28% is expected in the next year compared to the current price of 236.3.
For the next year, analysts expect an EPS growth of 23.27% and a revenue growth 5.14% for SRT3.DE